and pregnancy, while significant (P Ͻ 0.02) success was observed in transfers of embryos from the control group.
Introduction rhesus monkey, to examine in conception cycles with and
Progesterone is the powerhouse of the luteal phase; it induces without early luteal phase antiprogestin (mifepristone; changes in oviductal and uterine functions which are essential RU 486) treatment: (i) the growth status of preimplantafor embryo viability and implantation in a variety of species, tion embryos and (ii) the implantation ability of the preincluding primates (Edwards and Brody, 1995) . It has been implantation embryo after transfer to a synchronous-cycle shown that a timed administration of an antiprogestin such as surrogate recipient. A total of 43 proven fertile rhesus mifepristone (RU 486) on the second day after ovulation can monkeys were randomly placed in the control (group 1, n block implantation in rhesus monkeys (Ghosh and Sengupta, ⍧ 18) and mifepristone (group 2, n ⍧ 25) groups. All 1993) and in women (Gemzell-Danielson et al., 1993) . The monkeys cohabited with proven fertile male monkeys on anti-nidatory effect of early luteal phase antiprogestin treatment cycle days 8-16 and were injected with vehicle alone [benzyl theoretically can result from three physiological mechanisms. benzoate:olive oil, 1:4 (v/v), s.c.] for group 1 and with Firstly, RU 486 can act directly on the ovaries, or indirectly mifepristone (2 mg/kg body weight s.c.) for group 2, on on ovarian function through the hypothalamus-pituitaryday 2 after the presumed day of ovulation. A total of 12 ovary axis (DiMattina et al., 1986; Batista et al., 1992 ; preimplantation embryos [premorula (n ⍧ 1), morula (n Heikinheimo et al., 1995) . This mode of action, however, did ⍧ 2), zona-encased (n ⍧ 7) and zona-free (n ⍧ 1) not appear to be operative when a single, low dose (200 mg blastocysts and degenerate embryos (n ⍧ 1)] were recoorally in women and 2 mg/kg body weight s.c. in monkeys) vered from 17 ovulatory, mated cycles in group 1 on day of RU 486 was administered during the early post-ovulatory 6 after ovulation. In group 2, of the 23 ovulated cycles, 12 period, as this failed to induce any changes in the serum preimplantation embryos [premorula (n ⍧ 2), morula (n concentrations of oestradiol and progesterone during the luteal ⍧ 7), zona-encased blastocyst (n ⍧ 1), and degenerate phase and menstrual cyclicity was also not affected (Swahn embryos (n ⍧ 2)] were retrieved. Despite no significant et al., 1990; Ghosh and Sengupta, 1993) . difference in the recovery rate between the two groups, Secondly, mifepristone may act directly on progesterone early luteal phase RU 486 exposure induced delay (P Ͻ domination of the reproductive tract, causing embryo-0.01) in preimplantation embryo growth, primarily at the endometrial desynchronization and thus rendering the repromorula-blastocyst transition stage. Nine of the embryos ductive tract unfit for embryo implantation. In support of this, from group 1 and seven of the embryos from group 2 mifepristone is known to induce altered transit of ova and recovered on day 6 were transferred to naturally synchronembryos and cause associated egg loss in small laboratory ized, non-mated and untreated surrogate recipients. In animals (Fuentealba et al., 1987; Psychoyos and Prapas, 1987 ; group 1, five embryos implanted (55%) and, of these, three Roblero et al., 1987; Vinijsanun and Martin, 1990) . No specific (60%) gave rise to live infants through natural delivery; information is available for primates and women. However, implantation was assessed from extension of the cycle early luteal phase administration of mifepristone in monkeys (i.e. no menstrual bleeding) and rise in concentrations of and in women inhibits progesterone-induced typical endooestradiol and progesterone from day 10 of conception; metrial secretory transformation (Li et al., 1988 ; Johannisson rectal palpation was performed on cycle day 50 to confirm et al., 1989; Swahn et al., 1990; Berthois et al., 1991 ; Ghosh clinical pregnancy. In group 2, however, there was not Ghosh et al., 1996) . single case of establishment of pregnancy following transfer
Thirdly, antiprogestins such as RU 486 may affect growth of embryos retrieved from mifepristone-exposed monkeys.
and development of embryos before, and during, implantation. Thus, preimplantation embryos recovered from RU 486-exposed monkeys failed to establish evolutive implantation Available evidence from animal studies fails to provide any general consensus in this regard. Wolf et al. (1990) have shown that the growth rate and the implantation ability of preimplantation-stage embryos of cynomolgus monkeys were not affected directly by RU 486 in vitro. Roblero and Croxatto (1991) have reported that blastocysts transferred from RU 486-treated rats to synchronous untreated recipients showed delayed implantation. Thus, it has generally been presumed that implantation failure after early luteal phase administration of RU 486 to monkeys and to women is caused by endometrial asynchrony and hostility around the time of implantation (endometrial contraception). However, maternal signalling plays a permissive role in the growth and viability of the preimplantation embryo (Edwards and Brody, 1995; Tabibzadeh and Babaknia, 1995) . Recent studies indicate that RU 486 can specifically affect endometrial functions which are permissive towards embryo growth and/or embryo implantation (Graham et al., 1991; Antonakis et al., 1994; , 1994; Ding et al., 1994; Liu et al., 1994; Chaouat et al., and development of preimplantation embryos in small laboraembryos observed in our monkey colony (n ϭ 69). It is generally tory animal species (Psychoyos and Prapas, 1987; Roh et al., believed that rapidly developing embryos bear greater 1988; Psychoyos, 1989; Loutradis et al., 1991; McRae, 1994;  developmental potential compared with slowly growing embryos. The data shown were collected from the literature and our earlier Chen et al., 1995) . On the other hand, there are reports reports (Lewis and Hartman, 1933; Hendrickx and Kraemer, 1968;  indicating that progesterone is not absolutely essential for Hurst et al., 1980; Enders and Schlafke, 1981; Bavister et al., successful completion of preimplantation embryo development 1983; Sengupta et al., 1989 Sengupta et al., , 1995 .
in vivo in mice and in rats (Vinijsanun and Martin, 1990; Roblero and Croxatto, 1991) .
Treatment procedure
The question as to whether in-vivo growth and viability of
In this experiment, 43 female monkeys exhibiting at least two preimplantation-stage embryos are dependent on progesteroneconsecutive ovulatory menstrual cycles of normal length (28-32 days) mediated actions during the luteal phase in primates has not were randomly divided into two groups: group 1 (control; n ϭ 18) been addressed. In the present study we have examined this and group 2 (mifepristone treated; n ϭ 25). One monkey in group 1 question using early luteal phase treatment of rhesus monkeys and two monkeys in group 2 did not ovulate in the treatment cycles.
with high-affinity antiprogesterone-like RU 486. The experiThese three monkeys were discarded from the present study. Group 1 monkeys with ovulatory cycles (n ϭ 17) were allowed to cohabit mental objectives of the present study were: (i) to examine with males during cycle days 8-16, and were treated with vehicle on the growth status of preimplantation-stage embryos retrieved day 2 after the presumed day of ovulation. Group 2 female monkeys on day 6 of gestation from natural conception cycles with and (n ϭ 23) also cohabited with males during cycle days 8-16, and without early luteal phase mifepristone treatment, and (ii) to were injected with a single dose of mifepristone (RU 486; 2 mg/kg examine the implantation ability of these embryos after their body weight s.c.) in a vehicle composed of benzyl benzoate and olive transfer to naturally synchronized non-mated and untreated oil (1:4, v/v), as described previously (Ghosh and Sengupta, 1993) .
surrogate recipients.
Vaginal smears were checked daily for the presence of spermatozoa. Days of ovulation were determined from serum concentrations of immunoreactive oestradiol and progesterone as described elsewhere (Ghosh et al., 1994a,b) . In brief, the day of ovulation (D 0 ) was taken
Materials and methods
to be 24 h after the peak value of serum oestradiol concentration was Animals and general procedures measured. Adult, proven fertile male and female monkeys were housed under Experiment 1: growth status of preimplantation-stage embryos semi-natural conditions. The procedural details of animal housing, management, nutrition, monitoring of cycles, mating, laparotomy, On day 6 after ovulation, female monkeys of both groups were embryo retrieval, embryo transfer, endometrial sampling, serum laparotomized under ketamine (12 mg/kg body weight) anaesthesia collection and radioimmunoassays for serum concentrations of and their reproductive tracts were flushed with Dulbecco's minimum oestradiol and progesterone have been given elsewhere (Ghosh and Eagle's medium (pH 7.4) containing pyruvate (11 mg%, w/v), Sengupta, 1988 Sengupta, , 1989 Sengupta, , 1991 Sengupta, , 1992 . All experiments were conducted glutamate (58 mg%, w/v), glucose (100 mg%, w/v) and neomycin in the Primate Research Facility of the All India Institute of Medical (40 mg/ml) to retrieve preimplantation-stage embryos. These were Sciences, New Delhi. The study design was approved by the Ethics placed in small Petri dishes and rapidly examined with a dissecting Committee for the Use of Primates in Biomedical Research of the microscope. For assessing the growth status, embryos were examined All India Institute of Medical Sciences. All chemicals were obtained using a microscope with 80ϫ Nomarski optics. Stages of preimplantafrom Sigma Chemical Co. (St. Louis, MO, USA), unless stated tion embryo development were recorded as: premorula, morula, zonaencased blastocyst, zona-free blastocyst and degenerate embryo, as otherwise. embryo showing synchronous growth on day 6 after fertilization remained at premorula stage. Thus, preimplantation embryo is blastocyst (see Figure 1 ). After assessment of growth status, growth was significantly delayed (P Ͻ 0.01) compared with preimplantation embryos were either transferred to untreated naturally that of control monkeys when monkeys were treated with synchronous surrogate mothers or processed for a separate study.
mifepristone during the early luteal phase.
Experiment 2: implantation and pregnancy rates
Implantation and pregnancy after transfer of preimplantation
The selection of recipient surrogate mothers, the transfer of preembryos to naturally synchronized non-mated surrogate implantation embryos and monitoring of the establishment of pregrecipients nancy were performed according to the methods described earlier (Ghosh and Sengupta, 1991; Ghosh et al., 1994b) . Briefly, pre- Tables III and IV show the results of transfer of embryos implantation embryos from group 1 (n ϭ 9) and group 2 (n ϭ 7)
retrieved from control (group 1, Table III ) and mifepristonewere transferred within 30 min after their retrieval to naturally treated (group 2, Table IV) to implant as compared to control embryos. However, it should be noted that in one case (no. 2M) there was a rebound rise
Statistical analysis
in serum progesterone concentration with cycle extension
Comparisons between groups for different parameters were performed ( Figure 3c) ; however, this monkey was palpation-negative. A using the χ 2 test (Samuels, 1991) . similar case (no. 4C) was also observed in the control group (Figure 2b ). Results Table I gives details of embryos recovered from donor monkeys Discussion of group 1 and group 2 on day 6 after ovulation. The recovery of embryos from RU 486-treated monkeys (group 2;~52%)
A single-dose administration of a high-affinity antiprogestin such as mifepristone (RU 486) on day 2 after fertilization was less than that from control group monkeys (group 1; 70%); however, this difference was not statistically signiinhibits blastocyst implantation and establishment of pregnancy in women and in monkeys (Gemzell-Danielson et al., 1993; ficant. Ghosh and Sengupta, 1993; Ghosh et al., 1994a) . Comparable Growth status of preimplantation-stage embryos results were also obtained in other small laboratory animal species (Psychoyos and Prapas, 1987; Roh et al. 1988 ; Chen Table II shows the growth status of the preimplantation embryos recovered from monkeys in groups 1 and 2. After et al., 1995) . The mode of action of RU 486 in such protocols is not fully known. There is evidence in humans and monkeys mifepristone treatment (group 2), 16.7% embryos remained at ZFB ϭ zona-free blastocyst; ZEB, zona-encased blastocyst. a Occurrence of implantation was monitored from peripheral profiles of oestradiol and progesterone as shown in Figure 2 . Clinical pregnancy was detected by rectal palpation of the uterus. b See Figure 2b . There was a rise in serum progesterone concentration, with cycle extension, but the monkey was palpation-negative on day 50. c See Figure 2c . ZEB ϭ zona-encased blastocyst. a Occurrence of implantation was monitored from peripheral profiles of oestradiol and progesterone as shown in Figure 3 . Clinical pregnancy was detected by rectal palpation of the uterus. b See Figure 3c . There was a rise in serum progesterone concentration, with cycle extension, but the monkey was palpation-negative on day 50.
to suggest that early luteal phase treatment with mifepristone Sengupta, 1991; Ghosh et al., 1994a) and data from the present study clearly show that transfer of morulae during days 4-6 after results in inhibition of the progesterone-induced secretory maturation of the endometrium. The ensuing asynchronous ovulation to naturally synchronous recipient female monkeys results in a high rate of success (50-60%) with regard to pregnanchanges during the time of receptivity and implantation thereby cause a failure of endometrial support for implantation (Li cies in control transfer experiments. Peri-ovulatory administration of mifepristone to mice et Johannisson et al., 1989; Swahn et al., 1990; Berthois et al., 1991; Ghosh et al., 1992; resulted in reduced numbers of embryos retrieved on days 3 and 4 because of either early expulsion or destruction of et al., 1994; Ghosh et al., 1996) .
We now report a 25% decrease in the recovery rate of prepreimplantation embryos (Roh et al., 1988) . In a separate study, oral administration of RU 486 (100 mg/kg body weight/ implantation embryos from mifepristone-treated monkeys. Although this decrease was not statistically significant, the day) to mice on days 1 and 2 of pregnancy caused significant retardation in the development of preimplantation embryos embryos recovered exhibited a statistically significant delay in development. Thus, early luteal phase RU 486 treatment impairs (Yang and Wu, 1990) . When rats were treated with RU 486 (5 mg/kg or 10 mg/kg body weight/day) on days 1 and 2 of embryo development during the preimplantation period, primarily during the transition from morula to blastocyst. This pregnancy, morulae were found up to the evening of day 4, but on the morning of day 5, embryos could be detected in conclusion is supported by the data in Figure 1 as compared with the results of the present study. More importantly, the viability only 25% of the treated animals and none was at the blastocyst stage; they were either degenerate or morula-stage embryos of embryos recovered from antiprogestin-treated monkeys was compromised, since complete pregnancy failure occurred upon (Psychoyos and Prapas, 1987) . It is generally believed that preimplantation embryo developtransfer to non-treated synchronous recipient females. We believe that this failure did not result from the transfer of morulament is normally subject to progressive determination, and an in-built 'clock' appears to control the initiation of blastocyst stage embryos. Indeed, our previous reports (Ghosh and transfer. The lowest detectable sensitivity at 99% confidence confidence interval for oestradiol was 0.25 nmol/l, and for interval for oestradiol was 0.25 nmol/l, and for progesterone progesterone 2 nmol/l. The black boxes indicate menstrual 2 nmol/l. The black boxes indicate menstrual bleeding. bleeding.
differentiation. Seemingly, this 'clock' operates in terms of the number of nuclear and cytoplasmic cleavages (Edwards, morula-blastocyst transition and induces impairment of viability in the preimplantation-stage embryo. It should be 1980; Trounson, 1983) . In agreement with the available reports in small animals, we conclude that in the rhesus monkey noted that the typical response of a preimplantation mammalian embryo to a potentially harmful agent is an all-or-nothing administration of RU 486 on day 2 after ovulation in a conception cycle generally impairs embryo growth, delays response, resulting in either normal survival or death, which may account for the absence of malformations in surviving neither exogenous progestin nor dexamethasone could reverse this effect (McRae, 1994) . This model has the advantage of fetuses (Edwards, 1980) . Implantation is dependent more on embryonic development dissociating the effect of antiprogestin from that of antiprogestin-associated overt oestrogen dominance, since follicthan on endometrial maturation as long as the endometrium is in the receptive stage, which extends between cycle days 20 ular activity is suppressed during lactation. It has been reported that the effects of RU 486 treatment (on days 1 and 2 postand 24 (Bergh and Navot, 1992) . The implantation-stage primate embryo may withstand a delay of 2-3 days or longer coitum) associated with ovarian oestrogen dominance could be opposed by exogenous progesterone administration. Howand, indeed, the implantation window is relatively extended in primates (Rogers and Murphy, 1989; Edwards, 1994) . In ever, the anti-nidatory effect of antiprogestin could not be reversed in the rat (Psychoyos et al., 1995) . view of these two facts, we presume that the 100% failure rates for implantation and pregnancy after transfer of embryos It is now evident that progesterone-dependent stimulation of specific gene expression and repression in the uterus, some recovered from mifepristone-treated donors were caused by impairment of embryo viability. It has been shown in studies of which may be linked to embryo development, are altered by RU 486 (Ding et al., 1994; Psychoyos et al., 1995) . using non-primate laboratory species that embryos may undergo delayed implantation in mifepristone-treated cycles in Antonakis et al. (1994) have shown that RU 486 exhibits a complex regulatory action on cytokine liberation by human rats and rabbits provided luteolysis is prevented (Psychoyos and Prapas, 1987; Beier et al., 1994) , or in cases of transfer of lymphocytes, and have suggested that this antiprogestinantiglucocorticoid may interfere with endometrial lymphokine blastocysts from RU 486-treated rats to synchronous recipients (Roblero and Croxatto, 1991) . Nevertheless, most studies with production. Psychoyos and Prapas (1987) also suggested that it was more likely that the anti-progestagen was indirectly common laboratory animal species indicate a high degree of growth impairment, degeneration and loss of preimplantation responsible for the observed impairment of embryo development in the rat, mediated through changes in endometrial embryos (Psychoyos and Prapas, 1987; Roh et al., 1988; Roblero and Croxatto, 1991) . The results of the present study function and the composition of the intraluminal milieu. This idea is supported by the observation that passive immunization support the suggestion that progesterone-mediated action is required to promote preimplantation embryo development against progesterone during early pregnancy resulted in arrested embryonic growth in mice (Wang et al., 1984) , ferrets (Rider in mammals (Psychoyos and Prapas, 1987; McRae, 1994; Psychoyos et al., 1995) .
and Heap, 1986) and rats (Phillips et al., 1988) . Graham et al. (1991) demonstrated that mifepristone could prevent the RU 486 may exert a direct action on the preimplantation embryo, depending on its concentration and on the duration expression of a specific secretory glycan when given to women on day 2 after ovulation but not when it was given on day 5 of exposure (Juneja and Dodson, 1990; Wolf et al., 1990; Yang and Wu, 1990) . However, in the present study, the after ovulation. observed that several of the receptive-stage-specific endometrial marker concentration of RU 486 in oviductal and uterine fluid following injection of 2 mg/kg mifepristone s.c. on day 2 after proteins were diminished or absent from luminal fluid on the fourth day after mifepristone was administered to women on ovulation was not measured. Therefore, it was not possible to determine whether the observed impairment of embryo growth day LHϩ2. Our preliminary study (unpublished data) reveals that profiles of secretory proteins synthesized in vitro by and retardation of morula-blastocyst transition were caused by a direct action of RU 486 on the embryo. endometrium recovered on day 2 of gestation from monkeys after 4 days of treatment with mifepristone differ quantitatively Oviductal function may be also markedly altered in RU 486-exposed animals, causing altered embryo transport and and qualitatively from profiles from control endometrium. It is therefore possible that the endometrial luminal milieu differs embryo loss. This may result from the unopposed action of oestrogen and could be reversed by progestin treatment in RU 486-exposed conception cycles compared with control conception cycles around the time of the morula to blastocyst (Psychoyos and Prapas, 1987; Roblero et al., 1987; Roh et al., 1988; Vinijsanun and Martin, 1990; Psychoyos et al., 1995) . transformation and implantation.
In conclusion, the present study suggests that progesterone It is generally believed that the progesterone-oestrogen milieu plays a critical role in the transport of embryos through the receptor-mediated functions play a critical role in preimplantation embryo growth and development, and the maintenance of oviduct to the uterus (Edwards, 1980) . It is highly probable that this is affected in a mifepristone-treated cycle. It is known embryo viability. It has been suggested that any system which cannot support the normal cleavage rate and developmental that the uterine environment is neither refractory nor toxic either to embryo development or to subsequent implantation growth of embryos results in implantation failure (Trounson, 1983) . Many questions remain to be examined before a robust even during the very early stage of gestation in primates (Trounson, 1983) . However, it is not known whether possible model of an anti-nidatory mechanism for early luteal phase antiprogesterone treatment can be proposed. The nature and 'tube-locking' arising from the effect of unopposed oestrogen following progesterone receptor blockade, if it occurs at all, significance of changes in oviductal and endometrial functions in terms of embryo development in antiprogestin-exposed induces a deleterious signal to embryo growth and viability in the rhesus monkey.
conception cycles require further investigation. Ultrastructural and biochemical examinations of preimplantation-stage It has been shown that embryos recovered on day 4 of pregnancy from RU 486-treated lactating mice had signiembryos from RU 486-exposed mothers should be performed in order to define the nature of the drug-induced changes. The ficantly fewer cells than did those from control lactating mice;
